Biochemical Pharmacology SCIE

國際簡稱：BIOCHEM PHARMACOL 參考譯名：生化藥理學(xué)

主要研究方向：醫(yī)學(xué)-藥學(xué) 非預(yù)警期刊審稿周期：約1.0個月約3.3周

《生化藥理學(xué)》(Biochemical Pharmacology)是一本由Elsevier Inc.出版的以醫(yī)學(xué)-藥學(xué)為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽(yù)，影響因子不斷增加，發(fā)行量也同樣高。

2區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
457 年發(fā)文量
5.3 IF影響因子
未開放 是否OA
181 H-index
1958 創(chuàng)刊年份
Semimonthly 出版周期
English 出版語言

Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.

The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.

All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.

While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.

[ 查看全部 ]

投稿咨詢加急咨詢

Biochemical Pharmacology期刊信息

ISSN：0006-2952
出版語言：English
是否OA：未開放
E-ISSN：1873-2968
出版地區(qū)：UNITED STATES
是否預(yù)警：否
出版商：Elsevier Inc.
出版周期：Semimonthly
創(chuàng)刊時間：1958
開源占比：0.1174
Gold OA文章占比：20.83%
OA被引用占比：0.0641...
出版國人文章占比：0.16
出版撤稿占比：0
研究類文章占比：62.58%

Biochemical Pharmacology CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

10.3

1.365

1.106

學(xué)科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmacology	Q1	32 / 313	89%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Biochemistry	Q1	58 / 438	86%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標(biāo)。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Biochemical Pharmacology中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū)

Biochemical Pharmacology JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q1	34 / 354	90.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q1	32 / 354	91.1%

Biochemical Pharmacology歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Biochemical Pharmacology中國學(xué)者發(fā)文選摘

1、Sirtuin1-p53: A potential axis for cancer therapy
Author: Yin, Jia-yi; Lu, Xin-tong; Hou, Meng-ling; Cao, Ting; Tian, Zhen

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 212, Issue , pp. -. DOI: 10.1016/j.bcp.2023.115543
2、Inhibition of STX17-SNAP29-VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathway
Author: Liang, Xiao; Yu, Chunlei; Tian, Yunhong; Xiang, Xiaocong; Luo, Yuexi

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 212, Issue , pp. -. DOI: 10.1016/j.bcp.2023.115549
3、Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis
Author: Xie, Zheng; Wang, Xuan; Luo, Xiaoxiao; Yan, Jing; Zhang, Jie; Sun, Rao; Luo, Ailin; Li, Shiyong

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115374
4、The role of Notch signaling pathway in metabolic bone diseases
Author: Gao, Yongguang; Fu, Zhanda; Guan, Junxia; Liu, Xinhua; Zhang, Qing

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115377
5、Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines
Author: Gao, Jing; Zhou, Chen; Zhong, Yan; Shi, Li; Luo, Xuanyang; Su, Haixia; Li, Minjun; Xu, Yechun; Zhang, Naixia; Zhou, Hu

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115376
6、Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3K alpha inhibitors in gastric cancer cells
Author: Ma, Xu-Bin; Wang, Yang; Jia, Ying-Jie; Liu, Ya-Jie; Tian, Ying-Qi; Liu, Ying; Hou, Gui-Qin; Xu, Yi-Chao; Liu, Hong-Min

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115380
7、Exploring the potential molecular mechanism of trastuzumab-induced cardiotoxicity based on RNA sequencing and bioinformatics analysis
Author: Hou, Huan; Xu, Ying; Xie, Meilin; Chen, Rong

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 208, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115388
8、Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis
Author: Wang, Weixuan; Liang, Mingjie; Wang, Lexun; Bei, Weijian; Rong, Xianglu; Xu, Jianqin; Guo, Jiao

Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115357